This diverse collection of well-respected and experienced physicians, surgeons, and physicists confidentially advise Accuray Incorporated on the clinical direction of radiosurgery. The CAB is instrumental in guiding the evolution of treatment applications for and advising on clinical developments of the CyberKnife Robotic Radiosurgery System, and increasing industry awareness and clinical confidence. In addition, the CAB advises Accuray on product enhancements and technical advancements to ensure the maximum clinical value of the CyberKnife technology. The ultimate objective of the CAB is to help ensure the best treatment options for patients with cancer and other diseases throughout the body.